Valuation: Novartis AG

Capitalization 31TCr 27TCr 24TCr 23TCr 43TCr 28,78200Cr 44TCr 2,86200Cr 1,14600Cr 13,72600Cr 1,17200Cr 1,14700Cr 49,02300Cr P/E ratio 2026 *
22.2x
P/E ratio 2027 * 19.7x
Enterprise value 34TCr 30TCr 27TCr 26TCr 47TCr 31,79900Cr 49TCr 3,16200Cr 1,26600Cr 15,16500Cr 1,29500Cr 1,26700Cr 54,16300Cr EV / Sales 2026 *
5.97x
EV / Sales 2027 * 5.65x
Free-Float
87.19%
Yield 2026 *
2.69%
Yield 2027 * 2.82%
1 day-1.55%
1 week-1.76%
Current month-3.57%
1 month+5.50%
3 months+17.52%
6 months+21.02%
Current year+14.82%
1 week 125.68
Extreme 125.68
131
1 month 117.98
Extreme 117.98
131
Current year 107.68
Extreme 107.68
131
1 year 81.1
Extreme 81.1
131
3 years 73.74
Extreme 73.74
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO 61 24/04/2013
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 68 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Change 5d. change 1-year change 3-years change Capi.($)
-1.56%-1.76%+25.84%+58.85% 31TCr
-0.41%-2.46%+10.15%+215.16% 90TCr
-0.59%+0.05%+48.29%+59.27% 59TCr
+1.00%+4.09%+13.68%+51.35% 42TCr
-1.45%-2.64%+16.75%+30.77% 37TCr
-0.89%-0.64%+24.47%+39.77% 31TCr
+0.38%-1.78%+29.95%+12.54% 30TCr
+0.60%-1.32%+21.49%+61.52% 20TCr
+0.26%+0.75%+29.18%+82.83% 18TCr
+0.97%+3.75%-60.80%-50.88% 17TCr
Average -0.44%-0.28%+15.90%+56.12% 37.54TCr
Weighted average by Cap. -0.62%-0.62%+19.60%+83.76%

Financials

2026 *2027 *
Net sales 5.78TCr 4.97TCr 4.51TCr 4.33TCr 7.9TCr 5,32800Cr 8.18TCr 53TCr 21TCr 2,54100Cr 22TCr 21TCr 9,07500Cr 6.05TCr 5.21TCr 4.72TCr 4.53TCr 8.27TCr 5,58100Cr 8.57TCr 56TCr 22TCr 2,66200Cr 23TCr 22TCr 9,50600Cr
Net income 1.4TCr 1.2TCr 1.09TCr 1.05TCr 1.91TCr 1,28900Cr 1.98TCr 13TCr 5.13TCr 61TCr 5.25TCr 5.14TCr 2,19600Cr 1.58TCr 1.36TCr 1.23TCr 1.18TCr 2.16TCr 1,45500Cr 2.23TCr 14TCr 5.79TCr 69TCr 5.92TCr 5.8TCr 2,47800Cr
Net Debt 3.27TCr 2.81TCr 2.55TCr 2.45TCr 4.47TCr 3,01700Cr 4.63TCr 30TCr 12TCr 1,43900Cr 12TCr 12TCr 5,13900Cr 2.98TCr 2.56TCr 2.32TCr 2.23TCr 4.07TCr 2,74600Cr 4.22TCr 27TCr 11TCr 1,31000Cr 11TCr 11TCr 4,67800Cr
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
05/26/05 125.86 CHF -1.43% 13,56,117
04/26/04 127.68 CHF +1.01% 34,79,655
03/26/03 126.40 CHF -2.74% 40,07,072
02/26/02 129.96 CHF -0.41% 37,82,083
27/26/27 130.50 CHF +1.87% 58,63,388
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
163.62USD
Average target price
150.03USD
Spread / Average Target
-8.31%

Quarterly revenue - Rate of surprise